Wednesday, March 24
Opening Session
Moderator – Mark Pandori, PhD, San Francisco Department of Public Health, HIV Diagnostics Conference Planning Committee Chair
Evolution of HIV Diagnostics and Goals of the 2010 Conference
- Bernard Branson, MD, Centers for Disease Control and Prevention
HIV Testing in Public Health Laboratories: Results from the 2009 APHL HIV Testing Practices Survey
- Barbara Werner, PhD, Massachusetts Department of Health
- Steven Ethridge MT(ASCP), Centers for Disease Control and Prevention
Rapid Testing Algorithms at the Point of Care/Contact
Moderator – Kevin Delaney, MPH, Centers for Disease Control and Prevention
Lessons Learned from San Francisco’s Experience with Rapid Testing Algorithms
- Thomas Knoble, MSW, San Francisco Department of Public Health
- April Richardson-Moore, RN, MPH, New York State Department of Health
- Linda Styer, PhD, Wadsworth Center, New York
Statewide Implementation of Rapid-Rapid Testing in New Jersey
- Eugene G. Martin, PhD, UMDNJ – Robert Wood Johnson Medical School
Rapid Testing Algorithms at the Point of Care/Contact
Moderator – Michael Pentella, PhD, D(ABMM), University of Iowa Hygienic Laboratory
- Jacqueline Rurangirwa, MPH, County of Los Angeles, Department of Public Health, Office of AIDS Programs and Policy
Examination of an alternative algorithm for HIV diagnostics using HIV-1/2 rapid tests as confirmatory assays
- Silvina Masciotra, MS, Centers for Disease Control and Prevention
Expanded HIV Rapid Testing in Emergency Departments (ED) – Chicago, Illinois 2007-2008
- Nancy R. Glick, MD, Mt. Sinai Hospital, Chicago, IL
- Karen Reitan, MA, Public Health Institute of Metropolitan Chicago
Multiplexed POC Device for HIV and Co-Infection Serodiagnosis
- Michael Lochhead, PhD, mBio Diagnostics , Inc.
Bridging Point-of-Care/Contact & Laboratory Testing
Moderator – Kathleen Krchnavek, MSSW, Wisconsin Department of Health
Establishing Ongoing Competency Assessment to Maintain HIV Testing Skills
- Teri Dowling, MA, MPH, San Francisco Department of Public Health
A Successful HIV Testing Quality Assurance Program; New York State Experience
- Mara L. San Antonio-Gaddy, RN, MSN, New York State Department of Health
The Potential Effect of Alternative Algorithms on HIV Surveillance
- Kristen Mahle, MPH, Centers for Disease Control and Prevention
The HIV Bridge Algorithm: Linking Point-of-Care, Laboratory and Patient Care
- Berry Bennett, MPH, Florida Bureau of Laboratories
Thursday, March 25
Serologic Testing Methods
Moderator – William A. Meyer III, PhD, D(ABMM), Quest Diagnostics
- Kevin P. Delaney, MPH, Centers for Disease Control and Prevention
False-positive HIV Test Results Using a Peptide-based Enzyme Immunoassay (EIA) in Pregnant Women and Others
- Laura G. Wesolowski, PhD, Centers for Disease Control and Prevention
- Michael P. Busch, MD, PhD, Blood Systems Research Institute and UCSF
- Robert W. Coombs, MD, PhD, FRCPC, University of Washington
Testing for Recent HIV Infection
Moderator – S. Michele Owen, PhD, Centers for Disease Control and Prevention
- Michael P. Busch, MD, PhD, Blood Systems Research Institute and UCSF
- Sheila M. Keating, PhD, MSPH, Blood Systems Research Institute
Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA
- Silvina Masciotra, MS, Centers for Disease Control and Prevention
IgG3 as a Biomarker for Distinguishing Recent from Established HIV-1 Infection
- Kelly A. Curtis, PhD, Centers for Disease Control and Prevention
A Global Perspective: International Laboratory Poster Highlights
Moderators – Kenneth Landgraf, MS & Tony Tran, MPH, MT(ASCP), Association of Public Health Laboratories
- Dawit Assefa, Ethiopian Health & Nutrition Research Institute
- Elizabeth Dax, National Serology Reference Laboratory, Australia and Indonesian Collaborators
SMARTube as a Test for Recent Infection
- Reshma Kassanjee, University of the Witwatersrand, South Africa
- Mathabo Lebina, Laboratory Services, Ministry of Health and Social Welfare, Lesotho
The High Positive Immunoassay Confirms HIV-1 Infection and Avoids the Need of Confirmatory Tests
- Rodolfo Ochoa-Jimenez, Regional Hospital of Colima, Mexico
Fourth Generation Immunoassays
Moderator – Bernard Branson, MD, Centers for Disease Control and Prevention
Performance of the AxSym Ag/Ab HIV Combo assay, a 4th generation assay for routine HIV screening
- Christiane Claessens, MSc, INSPQ/LSPQ, Sainte-Anne-de-Bellevue, QC, Canada
Performance Evaluation of the Bio-Rad GS HIV Combo Ag/Ab EIA
- Kathleen Shriver, PhD, Bio-Rad Laboratories
- Patrick Kilmartin, B.Sc., M.Sc., Ortho Clinical Diagnostics
Clinical and Analytical Evaluation of the ARCHITECT®HIV Ag/Ab Combo Assay
- Barbara A. Kaesdorf, MS, MT(ASCP), CCRA, Abbott Diagnostics
- Mark Pandori, PhD, San Francisco Department of Public Health
Applications of Nucleic Acid Testing Technologies
Moderator – Sally Liska, DrPH, San Francisco Department of Public Health
Optimization of Abbott m2000 RealTime HIV-1 Viral Load Assay on Breastmilk, Dried Blood Spots, Genital Secretions, Cerebrospinal Fluid, Urine, and Throatwash
- Julie A. E. Nelson, PhD, University of North Carolina at Chapel Hill
Evaluating Kit-Based HIV-1 DNA PCR Protocol for Confirming Infection
- Carolyn D. Dawson, BS, Centers for Disease Control and Prevention
New HIV-1 RNA Assay Validation: Roche COBAS TaqMan and Abbott RealTime
- James Bremer, PhD, Rush University
Point-of-Care Molecular Diagnostics
- Marco Schito, PhD, Henry Jackson Foundation, DAIDS, NIH, Bethesda, MD
Friday, March 26
New Approaches in HIV Testing
Moderator – Steven Ethridge, MT(ASCP), Centers for Disease Control and Prevention
ELISA Strength of Signal in a Protocol to Prevent Mother-to-Child HIV Transmission
- Michael Loeffelholz, PhD, ABMM, University of Texas Medical Branch
- Timothy C. Granade, MS, Centers for Disease Control and Prevention
- Shixing Tang, MD, PhD, Food and Drug Administration
A novel method of creating molecular control used in the NLHRS HIV-2 Viral Load Assay and subsequent results in a NIBSC-WHO study to evaluate candidate international standards for HIV-2 RNA
- John Kim, PhD, National Laboratory for HIV Reference Services, Public Health Agency of Canada
Conference Wrap-Up & Next Steps
Moderated by Bernard Branson, MD, Centers for Disease Control and Prevention